Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rabe

Showing results (481-490 of 646) with videos related to

Pageof 65
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical TrialFernando J Martinez, Klaus F Rabe, Sanjay Sethi, et al.
Allergy|April 19, 2023
Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic statusKlaus F Rabe, Ian D Pavord, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|September 29, 2014
Bronchopulmonary lymph nodes and large airway cell trafficking in patients with fatal asthmaErika Feltrini Cagnoni, Diogenes Seraphim Ferreira, Luiz Fernando Ferraz da Silva, et al.
Pneumologie (Stuttgart, Germany)|June 10, 2010
[Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma]P Kardos, D Berdel, R Buhl, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics OutlookKlaus F Rabe, Stephen Rennard, Fernando J Martinez, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS StudyMasakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, et al.
The Lancet. Respiratory Medicine|March 5, 2022
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS studyMonica Kraft, Matthew Richardson, Brian Hallmark, et al.
Respiration; International Review of Thoracic Diseases|December 10, 2015
Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung BiopsiesMichael Kreuter, Detlef Kirsten, Thomas Bahmer, et al.
Pneumologie (Stuttgart, Germany)|August 10, 2000
[Inhalable corticosteroids in long-term COPD treatment. Opinions of an expert panel]A Gillissen, M Barczok, R Buhl, et al.
American Journal of Respiratory and Critical Care Medicine|August 2, 2003
Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure?Josephine de Kluijver, Christine E Evertse, Jacob K Sont, et al.
Pageof 65

Showing results (481-490 of 646) with videos related to

Sort By:
Pageof 65
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical TrialFernando J Martinez, Klaus F Rabe, Sanjay Sethi, et al.
Allergy|April 19, 2023
Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic statusKlaus F Rabe, Ian D Pavord, William W Busse, et al.
The Journal of Allergy and Clinical Immunology|September 29, 2014
Bronchopulmonary lymph nodes and large airway cell trafficking in patients with fatal asthmaErika Feltrini Cagnoni, Diogenes Seraphim Ferreira, Luiz Fernando Ferraz da Silva, et al.
Pneumologie (Stuttgart, Germany)|June 10, 2010
[Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma]P Kardos, D Berdel, R Buhl, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics OutlookKlaus F Rabe, Stephen Rennard, Fernando J Martinez, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS StudyMasakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, et al.
The Lancet. Respiratory Medicine|March 5, 2022
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS studyMonica Kraft, Matthew Richardson, Brian Hallmark, et al.
Respiration; International Review of Thoracic Diseases|December 10, 2015
Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung BiopsiesMichael Kreuter, Detlef Kirsten, Thomas Bahmer, et al.
Pneumologie (Stuttgart, Germany)|August 10, 2000
[Inhalable corticosteroids in long-term COPD treatment. Opinions of an expert panel]A Gillissen, M Barczok, R Buhl, et al.
American Journal of Respiratory and Critical Care Medicine|August 2, 2003
Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure?Josephine de Kluijver, Christine E Evertse, Jacob K Sont, et al.
Pageof 65